ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
Vor Biopharma Inc

Vor Biopharma Inc (VOR)

1.32
0.20
(17.86%)
終了 1月5日 6:00AM
1.2701
-0.0499
(-3.78%)
取引時間後: 9:52AM

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
1.2701
買値
1.28
売値
1.32
出来高
1,973,468
1.17 日の範囲 1.32
0.6354 52 週間の範囲 3.1399
時価総額
前日終値
1.12
始値
1.18
最終取引時間
財務取引量
US$ 2,474,266
VWAP
1.2538
平均取引量 (3 か月)
669,402
発行済株式数
68,673,612
配当利回り
-
PER
-0.77
1 株当たり利益 (EPS)
-1.72
歳入
-
純利益
-117.86M

Vor Biopharma Inc について

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33. Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.

セクター
Biological Pds,ex Diagnstics
業界
Biological Pds,ex Diagnstics
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Vor Biopharma Inc is listed in the Biological Pds,ex Diagnstics sector of the ナスダック市場 with ticker VOR. The last closing price for Vor Biopharma was US$1.12. Over the last year, Vor Biopharma shares have traded in a share price range of US$ 0.6354 to US$ 3.1399.

Vor Biopharma currently has 68,673,612 shares in issue. The market capitalisation of Vor Biopharma is US$76.91 million. Vor Biopharma has a price to earnings ratio (PE ratio) of -0.77.

VOR 最新ニュース

Vor Bio Announces $55.6 Million Private Placement

Intend to announce updated clinical data from Phase 1/2 VBP301 trial of VCAR33ALLO in the first half of 2025 and updated clinical data from Phase 1/2a VBP101 trial of trem-cel in combination with...

Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design

Preliminary data suggests improved relapse-free survival compared to published groups of acute myeloid leukemia (AML) patients at high risk of relapse post-transplantTrem-cel + Mylotarg continue...

Vor Bio to Participate in the Stifel 2024 Healthcare Conference

CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and...

Vor Bio Reports Third Quarter 2024 Financial Results and Provides Company Update

Company to present trem-cel + Mylotarg clinical data update at American Society of Hematology (ASH) 2024 annual meetingHan Choi, M.D., LL.M, seasoned healthcare institutional investor, appointed...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.280128.29292929290.991.350.9225618891.22891205CS
40.400145.98850574710.871.350.810581761.11005295CS
120.602390.19167415390.66781.350.63546694020.96419725CS
260.349437.94938633650.92071.350.63547205170.92201137CS
52-1.1299-47.07916666672.43.13990.63545264431.18272493CS
156-10.3999-89.11653813211.6712.730.63542662052.4119554CS
260-40.7499-96.977391718242.0263.620.63542427716.21398965CS

VOR - Frequently Asked Questions (FAQ)

What is the current Vor Biopharma share price?
The current share price of Vor Biopharma is US$ 1.2701
How many Vor Biopharma shares are in issue?
Vor Biopharma has 68,673,612 shares in issue
What is the market cap of Vor Biopharma?
The market capitalisation of Vor Biopharma is USD 76.91M
What is the 1 year trading range for Vor Biopharma share price?
Vor Biopharma has traded in the range of US$ 0.6354 to US$ 3.1399 during the past year
What is the PE ratio of Vor Biopharma?
The price to earnings ratio of Vor Biopharma is -0.77
What is the reporting currency for Vor Biopharma?
Vor Biopharma reports financial results in USD
What is the latest annual profit for Vor Biopharma?
The latest annual profit of Vor Biopharma is USD -117.86M
What is the registered address of Vor Biopharma?
The registered address for Vor Biopharma is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Vor Biopharma website address?
The website address for Vor Biopharma is www.vorbio.com
Which industry sector does Vor Biopharma operate in?
Vor Biopharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
260.93M
NITON2OFF Inc
US$ 2.6306
(145.85%)
358.28M
CRNCCerence Inc
US$ 19.33
(143.76%)
161.8M
KITTNauticus Robotics Inc
US$ 3.8249
(140.56%)
104.8M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.64M
HWHHWH International Inc
US$ 0.4621
(-28.80%)
7.43M
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 5.69
(-26.30%)
24.77M
RAINRain Enhancement Technologies Holdco Inc
US$ 5.59
(-23.42%)
161.15k
PTLEPTL Ltd
US$ 9.35
(-23.30%)
1.04M
NXUNXU Inc
US$ 0.725868
(-22.78%)
7.59M
NITON2OFF Inc
US$ 2.6306
(145.85%)
358.28M
TGLTreasure Global Inc
US$ 0.382
(101.58%)
337.5M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.64M
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
260.93M
NVDANVIDIA Corporation
US$ 144.47
(4.45%)
230.01M

VOR Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock